Fresenius Kabi Logo (Nal01 0006 01)
Naloxone Hydrochloride Injection, Solution
Product Images NDC 76045-112
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 76045-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula (Nal01 0006 02)
Not available.*
Figure 1 (Nal01 0006 03)
This text contains limited information related to a medical device. It mentions a "Plunger Rod," "Syringe Barrel," and "Syringe Tip Cap." The label states not to remove it. It seems like a component list or instructions related to assembling a syringe.*
Figure 2 (Nal01 0006 04)
Figure 3 (Nal01 0006 05)
Fresenius Kabi Logo (Nal01 0006 06)
Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Syringe Label)
This is a 1mL single-dose prescription-only solution from Fresenius Kabi containing HCl Injection with a concentration of mg/mL, suitable for IV, IM, or Subcutaneous use. The product code is N(01)00376045114010.*
Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Print Mat Label)
This text appears to be a description of a medication in a prefilled syringe. The medication is stored at a temperature between 20-25°C and needs to be protected from light. The dosage information is available in the package insert. It is important not to place the syringe on a sterile field. Unused portions should be discarded.*
Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Shelf Carton Panel)
Naloxone Hydrochloride Injection, USP is manufactured for intravenous, intramuscular, or subcutaneous use. Each mL contains 0.4 mg of naloxone hydrochloride, USP, and 9 mg of sodium chloride. It is adjusted with hydrochloric acid to meet USP limits. The usual dosage can be found in the package insert. Remember to store at 20°C to 25°C and protect from light. Avoid placing the syringe on the sterile field. Naloxone comes in a concentration of 0.4 mg/mL.*
Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Syringe Label)
This is a 2ml Single-Dose injection by Fresenius Kabi, intended for intravenous (IV), intramuscular (IM), or subcutaneous use. The medication contains 1 mg/mL of HCl. The product code is N(01)00376045112016.*
Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Print Mat Label)
Description: This text includes information about Naloxone, a medication in the form of a 2mg/2mL single-dose prefilled syringe. It is a Hydrochloride Injection for intravenous, intramuscular, or subcutaneous use. The storage instructions advise keeping it at 20°C to 5°C and protect it from light. The text also mentions to read the instructions, provide the usual dosage from the package insert, and not to place the syringe in a sharps container. The text indicates it is produced by Fresenius Kabi.*
Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Shelf Carton Panel)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
